This is how most people feel. I write not to offend in recreation. I record common and civilized opinion. I take none of this back. In solidarity with the reasonable many. And - no amount of rhetoric will scare me. You're not gonna win. nytimes.com/2024/04/23/opi…

This week on BT URO: Lindsay Hampson, Gina M. Badalato, and Max Bowman delve into leadership development during urology residency. #UroSoMe Columbia Urology Benjamin Breyer Michelle Van Kuiken, MD Carroll, Peter Thomas Chi Matt Cooperberg UroResidency james mckiernan UCSFUrology open.spotify.com/episode/5jmmgO…

We're so lucky to have Sarah P. Psutka MD MS speaking at UCSFUrology grand rounds on risk stratification and improving care for urologic malignancy!

Sima Porten Matt Cooperberg Benjamin Breyer Carissa Chu

Summary review of #TPvsTR evidence #State_of_the_Art just out today in BJU International

Is LATP really better than TR?

3 RCTs now out...larger/definitive trials to follow TRANSLATE Trial/The Patient-Centered Outcomes Research Institute #EAU24

Thanks Matt Cooperberg & Michael Jewett for commissioning!

bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bj…

Preliminary results of ProScreen trial: RCT, n=60,745 in 🇫🇮, comparing invitation to screen (PSA➡️4K➡️MRI) vs no invitation

jamanetwork.com/journals/jama/…

Enjoyed Badar M. Mian, MD presentation of #PROBE_PC trial.

Disease detection update: **NO DIFFERENCE** 😳

Such honesty about the travails of trying to run an RCT when everyone thought they already knew the answer!

Thanks for shout out to TRANSLATE Trial 🙏

#EAU24 European Association of Urology (EAU)

Freddie Hamdy & Richard Martin introduce 15yr f/u to #CAP_Study
=> now see small difference
0.7% vs 0.8% PCa death p=0.02
Need to screen 1000 men to save 1 life from PCa
PCa mortality <1% at 15yrs... (20% all cause)
#EAU24 European Association of Urology (EAU)

Nice summary of evidence so far on #TPvsTR debate from Dr Tourinho Confederación Americana de Urología (CAU)

One big omission from #TakeHomeMessages : the definitive trial TRANSLATE Trial is still to report. Properly powered. UK-conducted. Full #HealthEconomics analysis
n>1000, 10 centres...

#NotLongNow #eau24

Until someone shows me compelling data otherwise, proton therapy for prostate cancer is yet another black eye for American health care

Updated Analysis of Comparative Toxicity of Proton and Photon Radiation for Prostate Cancer ascopubs.org/doi/abs/10.120…

I'm so humbled to receive this incredible recognition! 🥹 A huge thanks to the residents for nominating me and making it all worth it! 🤍

Parsing the evidence from the #EMBARK trial on a promising new drug regimen in high-risk nonmetastatic hormone-sensitive #ProstateCancer . Matt Cooperberg UCSF Helen Diller Family Comprehensive Cancer Ctr joins Zach Klaassen Georgia Cancer Center in this conversation on UroToday > bit.ly/3RtOdtt

An honor to present today with my mentors and leaders in prostate cancer at the 4th Annual UC San Francisco / California Prostate Cancer Coalition Patient Conference on Prostate Cancer! Patients are at the center of everything we do here UC San FranciscoUrology ! Carroll, Peter Matt Cooperberg SamWashUro Hao Nguyen UC San FranciscoCancer